Severe Early-Onset Intrahepatic Cholestasis of Pregnancy Following Ovarian Hyperstimulation Syndrome with Pulmonary Presentation after In Vitro Fertilization: Case Report and Systematic Review of Case Reports.

early-onset intrahepatic cholestasis of pregnancy in vitro fertilization ovarian hyperstimulation syndrome pleural effusion ursodeoxycholic acid

Journal

Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444

Informations de publication

Date de publication:
16 Jan 2024
Historique:
received: 23 11 2023
revised: 03 01 2024
accepted: 16 01 2024
medline: 23 1 2024
pubmed: 23 1 2024
entrez: 23 1 2024
Statut: epublish

Résumé

Intrahepatic cholestasis of pregnancy (ICP) is the most common pregnancy-related liver disease, usually presented in the third trimester with pruritus, elevated transaminase, and serum total bile acids. Evidence shows that it can be developed in the first trimester, more commonly after in vitro fertilization (IVF) procedures, with the presence of ovarian hyperstimulation syndrome (OHSS). A literature search was conducted in the PubMed/MEDLINE database of case reports/studies reporting early-onset ICP in spontaneous and IVF pregnancies published until July 2023. Thirty articles on early-onset ICP were included in the review analysis, with 19 patients who developed ICP in spontaneous pregnancy and 15 patients who developed ICP in IVF pregnancies with or without OHSS. Cases of 1st and 2nd trimester ICP in terms of "early-onset" ICP were pooled to gather additional findings. Proper monitoring should be applied even before expected pregnancy and during IVF procedures in patients with known risk factors for OHSS and ICP development (patient and family history), with proper progesterone supplementation dosage and genetic testing in case of ICP recurrence.

Sections du résumé

BACKGROUND BACKGROUND
Intrahepatic cholestasis of pregnancy (ICP) is the most common pregnancy-related liver disease, usually presented in the third trimester with pruritus, elevated transaminase, and serum total bile acids. Evidence shows that it can be developed in the first trimester, more commonly after in vitro fertilization (IVF) procedures, with the presence of ovarian hyperstimulation syndrome (OHSS).
METHODS METHODS
A literature search was conducted in the PubMed/MEDLINE database of case reports/studies reporting early-onset ICP in spontaneous and IVF pregnancies published until July 2023.
RESULTS RESULTS
Thirty articles on early-onset ICP were included in the review analysis, with 19 patients who developed ICP in spontaneous pregnancy and 15 patients who developed ICP in IVF pregnancies with or without OHSS. Cases of 1st and 2nd trimester ICP in terms of "early-onset" ICP were pooled to gather additional findings.
CONCLUSIONS CONCLUSIONS
Proper monitoring should be applied even before expected pregnancy and during IVF procedures in patients with known risk factors for OHSS and ICP development (patient and family history), with proper progesterone supplementation dosage and genetic testing in case of ICP recurrence.

Identifiants

pubmed: 38255744
pii: life14010129
doi: 10.3390/life14010129
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Auteurs

Stipe Dumančić (S)

Department of Obstetrics and Gynecology, Clinical Hospital Center Split, 21 000 Split, Croatia.

Mislav Mikuš (M)

Department of Obstetrics and Gynecology, Clinical Hospital Center Zagreb, 10 000 Zagreb, Croatia.

Zdenka Palčić (Z)

Department of Obstetrics and Gynecology, Clinical Hospital Center Split, 21 000 Split, Croatia.

Dubravko Habek (D)

School of Medicine, Catholic University of Croatia, Ilica 242, 10 000 Zagreb, Croatia.

Mara Tešanović (M)

Department of Obstetrics and Gynecology, General Hospital Dubrovnik, 20 000 Dubrovnik, Croatia.

Marko Dražen Mimica (MD)

Department of Obstetrics and Gynecology, Clinical Hospital Center Split, 21 000 Split, Croatia.

Jelena Marušić (J)

Department of Obstetrics and Gynecology, Clinical Hospital Center Split, 21 000 Split, Croatia.
School of Medicine, University of Split, Soltanska 2, 21 000 Split, Croatia.
University Department of Health Studies, University of Split, R. Boskovica 35, 21 000 Split, Croatia.

Classifications MeSH